Redsense Medical has received the sad news of Malin Almgren’s sudden passing.

Malin Almgren has been a dedicated member of the board since May 2023 and has with her strong research focus provided valuable insights to the company.

"We will remember Malin for her calm presence, sharp mind, investigative drive, and patient focus; our thoughts are with Malin’s family and friends during this difficult time." says Susanne Olauson, Chair of the Board of Directors at Redsense Medical AB.

Redsense Medical’s nomination committee will present a proposal for new board members ahead of the upcoming annual general meeting.

Contact information

For more information, please contact: 
Susanne Olauson, Chair of the Board of Directors
Telephone: +46 73-230 9708
E-mail: Susanne.olauson (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862

About Redsense Medical

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector. The Redsense Medical share is listed on Spotlight Stock Market (REDS).